Get the Stockscreener App
5.20
0.00%
0.04
Beyond Air Inc stock is traded at $5.20, with a volume of 2,403.
It is up +0.00% in the last 24 hours and down -12.54% over the past month.
Beyond Air Inc a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. Its segments are Beyond Air, Beyond Cancer, and NeuroNos. The company generates majority of revenue from Beyond Air. It has developed the Beyond Air NO generator and delivery system which it call LungFit, a novel and precise delivery system that uses NO generated from ambient air with a novel NO generator, the ionizer. Its product and technology includes LungFitPH.
See More
Previous Close:
$5.16
Open:
$5.3
24h Volume:
2,403
Relative Volume:
0.09
Market Cap:
$4.99M
Revenue:
$7.68M
Net Income/Loss:
$-34.33M
P/E Ratio:
-0.059
EPS:
-88.1566
Net Cash Flow:
$-19.17M
1W Performance:
-18.29%
1M Performance:
-12.54%
6M Performance:
-74.46%
1Y Performance:
-87.48%
1-Day Range:
$5.21
$5.30
1-Week Range:
$5.01
$6.25
52-Week Range:
$5.01
$95.60
Beyond Air Inc Stock (XAIR) Company Profile
Name
Beyond Air Inc
Sector
Industry
Phone
516-665-8200
Address
900 STEWART AVENUE, GARDEN CITY, NY
Compare XAIR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XAIR
Beyond Air Inc
|
5.21 | 4.99M | 7.68M | -34.33M | -19.17M | -88.16 |
ABT
Abbott Laboratories
|
114.68 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.90 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.28 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.62 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.50 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Beyond Air Inc Stock (XAIR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-17-25 | Initiated | D. Boral Capital | Buy |
| Jun-25-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jul-28-23 | Initiated | Piper Sandler | Overweight |
| Jun-15-23 | Initiated | BTIG Research | Buy |
| Apr-28-21 | Initiated | Truist | Buy |
| Oct-22-19 | Initiated | Oppenheimer | Outperform |
View All
Beyond Air Inc Stock (XAIR) Latest News
Balyasny Asset Management L.P. Buys Beyond Air Inc (XAIR) -- Sha - GuruFocus
Beyond Air Inc (XAIR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Beyond Air | 8-K: Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update - Moomoo
Form 8K Beyond Air Inc For: 18 August By Investing.com - Investing.com Nigeria
Beyond Air (NASDAQ: XAIR) resale may lift share count to 6.2M - Stock Titan
Beyond Air Q2 net loss hits USD 7.9M - Medical Buyer
Cash per share of Beyond Air, Inc. – FWB:48L - TradingView
Beyond Air Inc (XAIR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Lucid, Beyond Air, Conagra Stocks Hit 52-Week Lows: What's Behind The Drag? - Stocktwits
XAIR Q2 2026 Earnings: Narrower Loss Fails to Stem 8.74% Stock DeclineEarnings Sentiment Score - Vinanet
Beyond Air Sticks to Revenue Targets as LungFit PH Gen II FDA Decision Nears - finance.biggo.com
Beyond Air Inc (XAIR) Stock News Today - TradingKey
Beyond Air (XAIR) Surges 14.4% to $6.92 as Bulls Defend SupportRisk Parity Rebalance - Vinanet
Beyond Air (XAIR) gains 5.30% beneficial owner as Balyasny Asset Management reports 763,266 shares - Stock Titan
XAIR|Beyond Air Inc|Price:7.160|Chg%:+1.110 - TradingKey
Beyond Air (XAIR) Earnings Call zum 1. Quartal des Geschäftsjahres 2027: FDA-Katalysator, Ausblick von 8 Mio. USD für 2026 - TradingKey
Beyond Air (XAIR) Fiscal Q1 2027 Earnings Call: FDA Catalyst, $8M 2026 Outlook - TradingKey
XAIR|Beyond Air Inc|Price:6.315|Chg%:-0.605 - TradingKey
Beyond Air earnings missed by $0.10, revenue fell short of estimates - Investing.com Canada
Beyond Air (XAIR) Q1 2027 Earnings Call Transcript - AOL.com
Beyond Air Inc (XAIR) (Q1 2027) Earnings Call Highlights: Strate - GuruFocus
Beyond Air Inc (XAIR) (Q1 2027) Earnings Call Highlights: Strategic Financing and Pipeline ... - Yahoo Finance UK
Beyond Air, Inc. Q1 2027 Earnings Call Summary - Yahoo Finance
Beyond Air (XAIR) posts $7.9M loss and cites funding risk in quarter - Stock Titan
Beyond Air, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2026 - marketscreener.com
Beyond Air Inc (NASDAQ: XAIR) Share Price, XAIR Stock News, XAIR Share Price & Updates - Kalkine
Beyond Air Releases Q1 2027 Financial Results - AlphaStreet
XAIR: Gross margin rose to 13% as pipeline doubled and 2026 revenue guidance was reaffirmed at $8M - TradingView
Beyond Air Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings call transcript: Beyond Air misses Q1 2027 revenue view, shares fall premarket - Investing.com
Beyond Air Q1 Results: EPS Misses Estimate, Sales Flat YoY - scanx.trade
Beyond Air Q1 FY27 net loss widens to $8.15 million; revenue flat at $1.77 million - Bitget
BEYOND AIR ($XAIR) Releases Q1 2027 Earnings - Quiver Quantitative
Beyond Air Q1 net loss slightly widens, reaffirms 2026 outlook - TradingView
Beyond Air Reports $1.8 Million Q2 Revenue, Reaffirms 2026 and 2027 Guidance as FDA Reviews Second-Generation LungFit PH System - Quiver Quantitative
Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update - marketscreener.com
Qubeyond Air, Inc. Reaffirms Earnings Guidance for the for Calendar Year 2026 and for 2027 - marketscreener.com
XAIR Q1'26 Earnings: EPS estimate is (10.80) USD - TradingView
Beyond Air Inc expected to post a loss of $10.80 a shareEarnings Preview - TradingView
Earnings Preview: Beyond Air to Report Financial Results on August 13 - Moomoo
Beyond Air Regains Nasdaq Compliance After Reverse Stock Split - The Globe and Mail
Beyond Air regains Nasdaq compliance after reverse stock split - Investing.com
Beyond Air regains Nasdaq compliance after reverse stock split By Investing.com - Investing.com Nigeria
Beyond Air regains Nasdaq bid-price compliance after 1-for-20 reverse split; discretionary monitor imposed - TradingView
Form 8K Beyond Air Inc For: 6 August By Investing.com - Investing.com Canada
Beyond Air (NASDAQ: XAIR) regains compliance, faces 1-year Nasdaq monitor - Stock Titan
XAIR Q1'26 Earnings: revenue estimate is 1.86M USD - TradingView
XAIR Q1'26 Earnings: EPS estimate is (10.10) USD - TradingView
Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026 - The Manila Times
Beyond Air will webcast results for quarter ended June 30 - Stock Titan
Beyond Air (XAIR) Q2 2026 Earnings: EPS Misses Estimates, Stock Slips 2.68%Weak Earnings Momentum - Vinanet
Beyond Air Inc Stock (XAIR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.59%
0.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):